Legal sector defies headwinds with 4% headcount growth
UK legal firms show resilience with 4% headcount growth and rising partner profits, while navigating cyber threats and cautious AI adoption. Discover the sector's 2025 outlook.
Category : Search result: pharmaceutical profits
NHS faces generic-only drug future warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
Wise Profits Dip as US Listing Move Confirmed
London-based fintech pioneer Wise reports 22% profit decline amid strategic shift to US primary listing, raising questions about UK's appeal to tech giants.
Novo Nordisk cuts forecasts again as drug demand slows
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
Clearsprings Profits Plunge in Asylum Accommodation Crisis
Exclusive investigation reveals dramatic profit decline at Clearsprings Ready Homes, the billion-pound firm housing asylum seekers across Britain, amid growing controversy over accommodation standards.
M&S profits plunge 90% after cyber attack
Retail giant Marks & Spencer reveals devastating financial impact of cyber attack as annual profits nearly wiped out, dropping from £32.4 million to just £2.5 million.
M&S profits plunge over 50% after cyber attack
Retail giant Marks & Spencer reports profits more than halved after sophisticated cyber attack disrupts operations and forces costly recovery measures.
UK Farming Crisis: Third of Farmers Made No Profit
Shocking new data reveals nearly a third of UK farmers operated at break-even or loss in the past year, threatening Britain's food security and rural economy.
BP profits plunge 70% as oil prices retreat
BP reports staggering 70% profit drop as oil prices retreat from Ukraine war peaks. Discover how the energy titan is navigating market turbulence while maintaining shareholder payouts.
Big Pharma's Tax Breaks: Are We Getting NHS Value?
Exclusive analysis reveals pharmaceutical giants received massive tax incentives while NHS faces funding crisis. Experts demand transparency on whether these breaks are delivering promised benefits to UK healthcare.
Ryanair profits soar 42% as CEO attacks Chancellor
Ryanair reports record €2.18bn annual profits while CEO Michael O'Leary blasts Chancellor Jeremy Hunt's economic policies as 'dismal' and 'miserable' for UK growth.
Salesforce UK profits surge 82% despite job cuts
Tech giant Salesforce sees UK profits surge by 82% to £52.6 million while implementing significant workforce reductions and strategic restructuring across its British operations.
Ryanair profits jump 42% on higher air fares
Europe's largest budget airline reports staggering profit surge driven by higher ticket prices and strong summer demand, with passenger numbers hitting new heights.
Novo Nordisk Bids for Metsera, Challenging Pfizer's Offer
Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.
Shell profits smash £43bn on Brazil and Gulf production surge
Energy giant Shell reports staggering £43 billion profits as production hits unprecedented levels in Brazil and Gulf of Mexico operations, reshaping global energy markets.
Trump-Xi Trade Deal Sends Oil Prices Soaring
Global markets surge as Trump and Xi announce major trade breakthrough, sending oil prices skyrocketing and triggering a rally across London's FTSE 100.
UK Pharma Crisis: Patients Face Treatment Delays
A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.
AI Bubble Fears Overshadow Tech Titans' Earnings
As Microsoft, Alphabet and Meta report impressive quarterly results, growing investor anxiety about an artificial intelligence bubble threatens to dampen the celebration. Discover why Wall Street is getting nervous about the AI gold rush.
Alphabet Smashes Records With £89.5 Billion Quarter
Google's parent company Alphabet reports another blockbuster quarter, with revenue soaring to £89.5 billion driven by AI breakthroughs and cloud computing dominance. Discover how the tech giant continues to defy market expectations.
GSK CEO warns UK drug pricing reforms threaten life sciences
Emma Walmsley warns Britain's life sciences industry faces 'existential threat' from proposed drug pricing reforms that could drive investment and research overseas.
European banks miss out as Wall Street deal boom returns
As US investment banks celebrate resurgent 'animal spirits' and soaring profits from revived M&A and IPOs, their European counterparts watch from the sidelines, missing out on the lucrative post-pandemic deal frenzy.
Page 2 of 2